EN DE
Watch Diversified Healthcare Trust for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Diversified Healthcare Trust (DHC) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Diversified Healthcare Trust stock $6.16, price $7.02, that is 12.3% below the price, quality 38 out of 100. Rating: overvalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Real Estate US

DH Diversified Healthcare Trust logo Thin data Nov 4, 2026

Diversified Healthcare Trust

DHC · US
Expensive, weak quality

Our calculation puts a fair price 12% below what the stock costs today.

Upbeat coverage
Moderate debt
0.6% dividend yield · Token dividend
Profit last quarter 68% below a year ago.
Fair value $6.16 · Overvalued
Quality 38/100
Weak Growth (revenue 5y −1.2 %/yr in USD)
Loss-making · -17.7% net margin (TTM)
Negative free cash flow
Trails peers (3/13)
Narrow moat 11/100
Thin data
Watch Diversified Healthcare Trust for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$9.63 $0.5892 Fair Value $6.16 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.

How to read this chart

60‑month range $0.5892 – $9.63 · fair‑value band $2.25 – $10.07 · the $7.02 price screens above the $6.16 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 4, 2026.

Follow Diversified Healthcare Trust in your weekly email

Every Wednesday you see whether Diversified Healthcare Trust is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Diversified Healthcare Trust is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States.

Show moreShow less

DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location.

As of March 31, 2026, DHC's approximately 6.2 billion dollars portfolio included 285 properties in 33 states and Washington, D.C., with 23,901 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants.

DHC is managed by The RMR Group, a leading U.S. alternative asset management company with over 37 billion dollars in assets under management as of March 31, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate.

DHC is headquarters in Newton, MA. Diversified Healthcare Trust was incorporated in 1998 in Maryland.

Stock analysis

Diversified Healthcare Trust (DHC) currently trades at $7.02, while our model-based Fair Value estimate is $6.16, 12% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 96/100, which puts the data coverage at low.

Scenario range: $2.25 (bear) to $10.07 (bull), the price of $7.02 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 38/100 (below-average quality), in the Real Estate sector.

Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.

Diversified Healthcare Trust reported revenue of $1.5B in FY2025 versus $1.4B in FY2021, a compound +2.7%/yr. Reported net income was −$286M in FY2025.

Key figures

Market cap $1.7B Small · P/S ratio 1.22 · EPS (TTM) $−1.08 · Dividend yield 0.6% · Net margin −17.7% · Return on equity −15.5% · Return on assets (EBIT) 1.1% (5-year average) · Operating margin −0.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 11 out of 100 (medium confidence).

What moves the price

The share trades about 27% below its 52-week high and 59% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Real Estate peers we cover trades at −19% fair-value upside, at −12%, DHC screens cheaper than that median.

Fair Value models

Bear $2.25 Fair Value $6.16 Bull $10.07
Price $7.02 · Downside -12.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EV/EBITDA $2.25 $6.16 $10.07 62
NCAV (Graham) $3.40 $4.55 $6.79 54
All 2 models by family
Multiples
EV/EBITDA $2.25 $6.16 $10.07 62
Asset-Based
NCAV (Graham) $3.40 $4.55 $6.79 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 38/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 4
How much profit the company makes from its sales and capital
Quality Growth 36
Are margins and returns getting better?
Cashflow 31
Do the profits arrive as real cash?
Financial strength 23
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 25
How calm the share price moves, does not count
Price momentum 49
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 75
Distance to the 52-week high, does not count
New shares 79
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, no officer or director bought or sold shares on the open market.

  • BuyChristopher J. BilottoPresident and CEO, Director20,000 shares at $4.89$97,800Dec 15, 2025

Plus 13 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 8/100
Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Revenue growth 1 year
+2.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.2%
Start year 2020 (pandemic). Over 10 years: +4.4% a year
Revenue growth 27 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
22.3% (2020) → −2.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

DHC screens overvalued: fair value 12% below the price. Compare with Welltower Inc →

Earlier news

News mood ⓘNews mood, the average tone of recent news (94 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.

Compare Diversified Healthcare Trust with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.REIT - Healthcare Facilities · 25 stocks

Beats the industry median on 3/12 measures
Overall it trails its industry peers.
Valuation
Quality Score 38 · Bottom 25%
Fair Value upside −12.3% · Below median
Profitability
Return on assets −6.6% · Bottom 25%
Net margin (12 months) −17.7% · Bottom 25%
Operating margin (12 months) −0.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −4.5% · Bottom 25%
Dividend yield (12 months) 0.6% · Bottom 25%
Balance sheet
Debt / equity 1.44× · Highest 25%

Valuation Multiplesvs REIT - Healthcare Facilities median · lower = cheaper

P/B 1.05× · Cheaper than median
P/S (12 months) 1.16× · Cheapest 25%
EV/EBITDA 18.2× · Pricier than median
PEG 1.89× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)17 · sector 34
FUTURE (revenue growth)0 · sector 49
PAST (return on equity)0 · sector 31
HEALTH (low debt)28 · sector 74
DIVIDEND (yield)11 · sector 100

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
National Health Investors, Inc NHI $71.24 $90.17 +27% vs DHC
Omega Healthcare Investors, Inc OHI $48.19 $58.51 +21% vs DHC
Healthcare Realty Trust Incorporated HR $19.20 $20.82 +8% vs DHC
Sabra Health Care REIT, Inc SBRA $21.02 $22.18 +6% vs DHC
CareTrust REIT, Inc CTRE $38.21 $31.01 −19% vs DHC
Healthpeak Properties, Inc DOC $20.26 $16.07 −21% vs DHC
Aedifica NV AED €65.65 €51.37 −22% vs DHC
Ventas, Inc VTR $88.75 $33.27 −63% vs DHC
Welltower Inc WELL $245.01 $74.12 −70% vs DHC
American Healthcare REIT, Inc AHR $57.91 $12.76 −78% vs DHC

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Diversified Healthcare Trust: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Diversified Healthcare Trust Fair Value". https://www.fairvalue-calculator.com/stock/DHC

Frequently asked questions

Is Diversified Healthcare Trust (DHC) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of $6.16 versus a price of $7.02, about 12% lower (overvalued).
What is the fair value of DHC?
Our model-based fair value for Diversified Healthcare Trust is $6.16 (as of Nov 4, 2026), built from audited fundamentals. The current price: $7.02.
What is the quality score of DHC?
Diversified Healthcare Trust has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Diversified Healthcare Trust (DHC)?
Our model-based price target is the fair value of $6.16 (as of Nov 4, 2026) from 2 valuation models. Cautious scenario $2.25, optimistic scenario $10.07. It is a calculation from audited fundamentals, not an analyst target.
What is the Diversified Healthcare Trust stock forecast for 2026?
Our models put fair value at $6.16, about 12% lower versus a price of $7.02 (overvalued). Cautious scenario $2.25, optimistic scenario $10.07. The calculation is refreshed regularly with new filings.
What is the revenue of Diversified Healthcare Trust (DHC)?
Diversified Healthcare Trust reported trailing-twelve-month revenue of about $1.5B (latest available figure, as of Nov 4, 2026).
Does Diversified Healthcare Trust pay a dividend?
Diversified Healthcare Trust currently shows a dividend yield of 0.57% relative to its recent price (as of Nov 4, 2026).
How much is the dividend of Diversified Healthcare Trust (DHC) and when is the ex-dividend date?
Diversified Healthcare Trust pays a dividend of $0.04 per share a year, a dividend yield of 0.6%. The last ex-dividend date was Oct 19, 2026. A dividend has been paid every year since at least 1999. Our assessment: Token dividend. At a yield of 0.6% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.6% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of Diversified Healthcare Trust (DHC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Diversified Healthcare Trust it is $6.16 per share (as of Nov 4, 2026), against a price of $7.02. It is the blended result of 2 valuation models in 2 families (Multiples, Asset-Based).
Is Diversified Healthcare Trust stock overvalued or undervalued in 2026?
As of Nov 4, 2026, DHC trades above its calculated fair value: price $7.02, fair value $6.16, a gap of about −12% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DHC?
No. The price is what the market pays today ($7.02); the fair value is what the company's own numbers justify ($6.16). For Diversified Healthcare Trust the two are $0.8600 per share apart. That gap is exactly why we show both numbers side by side.
How much is Diversified Healthcare Trust worth?
The market values Diversified Healthcare Trust at about $1.7B (market capitalisation, as of Nov 4, 2026). Per share that is $7.02; our models calculate a fair value of $6.16 per share.
What do the bullish and bearish scenarios say about DHC?
Our models span a range for Diversified Healthcare Trust: cautious scenario $2.25, base $6.16, optimistic $10.07 per share (as of Nov 4, 2026, price $7.02). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of DHC?
The PEG ratio of Diversified Healthcare Trust is 1.89 (P/E divided by earnings growth, as of Nov 4, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Diversified Healthcare Trust (DHC)?
Balance-sheet figures for Diversified Healthcare Trust (as of Nov 4, 2026): return on equity −15.5%, debt of 1.44 per unit of equity. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is DHC from its 52-week high?
Diversified Healthcare Trust trades at $7.02, about 27% below its 52-week high of $9.63 and 59% above the low of $4.43 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $6.16 is for.
Which stocks are comparable to Diversified Healthcare Trust?
From the same area (Real Estate) we also value Welltower Inc, Ventas, Inc, Omega Healthcare Investors, Inc, Healthpeak Properties, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Diversified Healthcare Trust stock attractive at the current price?
The data as of Nov 4, 2026: price $7.02, calculated fair value $6.16 (−12%), Quality Score 38/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of DHC calculated?
We run Diversified Healthcare Trust through 2 models from 2 families: Multiples, Asset-Based. Every model gets the same audited fundamentals; the fair value of $6.16 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Diversified Healthcare Trust itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Diversified Healthcare Trust (DHC)?
The closing price on Nov 6, 2026 was $7.02. Our model-based fair value is $6.16, about 12% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Diversified Healthcare Trust right now?
The model range is unusually wide ($2.25 to $10.07). The outcome hinges heavily on assumptions, so read the point estimate with caution. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.

Key figures of Diversified Healthcare Trust

How large is the market capitalisation of Diversified Healthcare Trust (DHC)?
The market capitalisation of Diversified Healthcare Trust is $1.7B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Diversified Healthcare Trust (DHC)?
The price-to-sales ratio of Diversified Healthcare Trust is 1.22 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Diversified Healthcare Trust (DHC)?
Earnings per share at Diversified Healthcare Trust are $−1.08. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Diversified Healthcare Trust (DHC)?
The dividend yield of Diversified Healthcare Trust is 0.6%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Diversified Healthcare Trust (DHC)?
The net margin of Diversified Healthcare Trust is −17.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Diversified Healthcare Trust (DHC)?
The return on equity (ROE) of Diversified Healthcare Trust is −15.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Diversified Healthcare Trust (DHC)?
On an EBIT basis the return on assets of Diversified Healthcare Trust is 1.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Diversified Healthcare Trust (DHC)?
The operating margin of Diversified Healthcare Trust is −0.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Diversified Healthcare Trust (DHC)?
Revenue at Diversified Healthcare Trust is growing −4.5% versus a year earlier (3y avg +6.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Diversified Healthcare Trust (DHC)?
Earnings per share at Diversified Healthcare Trust are growing −68.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Diversified Healthcare Trust (DHC) generate?
The free cash flow of Diversified Healthcare Trust is −$19.6M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Diversified Healthcare Trust (DHC) carry?
The net debt of Diversified Healthcare Trust is $2.3B (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Diversified Healthcare Trust in the live analysis

One click puts Diversified Healthcare Trust on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.